WallStreetZenWallStreetZen

NASDAQ: IMRN
Immuron Ltd Earnings & Revenue

OverviewEarnings
DividendOwnership

IMRN past revenue growth

How has IMRN's revenue growth performed historically?
Company
224.3%
Industry
145.73%
Market
17.2%
IMRN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IMRN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IMRN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IMRN earnings and revenue history

Current Revenue
$2.4M
Current Earnings
-$2.6M
Current Profit Margin
-108.5%

IMRN Return on Equity

Current Company
-20%
Current Industry
-63.5%
Current Market
188%
IMRN's Return on Equity (-20%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when IMRN announces earnings.

IMRN Return on Assets

Current Company
-18.1%
Current Industry
2.9%
IMRN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

IMRN Return on Capital Employed

Current Company
-21.93%
Current Industry
19.5%
IMRN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IMRN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
IMRN$2.34MN/A-$2.54M+12.68%N/A
IMNN$0.00-$19.88M-$19.51M-100.00%N/A
TNXP$7.77M-$112.37M-$116.66MN/AN/A
EDSA$0.00-$7.52M-$7.72M-100.00%N/A
PIRS$42.81M-$22.76M-$24.54M+8.03%N/A
View Top Biotech Stocks

Immuron Earnings & Revenue FAQ

What were IMRN's earnings last quarter?

On Invalid Date, Immuron (NASDAQ: IMRN) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Immuron earnings for the quarter were N/A. In the same quarter last year, Immuron's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Immuron stock.

What was IMRN's earnings growth in the past year?

As of Q2 2024, Immuron's earnings has grown year over year. Immuron's earnings in the past year totalled -$2.54 million.

What was IMRN's revenue last quarter?

On Invalid Date, Immuron (NASDAQ: IMRN) reported Q4 2023 revenue of N/A up N/A year over year. In the same quarter last year, Immuron's revenue was N/A.

What was IMRN's revenue growth in the past year?

As of Q2 2024, Immuron's revenue has grown 224.3% year over year. This is 78.57 percentage points higher than the US Biotechnology industry revenue growth rate of 145.73%. Immuron's revenue in the past year totalled $2.34 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.